Guidelines for frozen plasma transfusion

British Columbia Medical Journal

Volumn 49, Issue 6, 2007, Pages 311-319

  Wong, Michelle P ^a   Droubatchevskaia, Nadejda ^a   Chipperfield, Kate M ^a,b   Wadsworth, Louis D ^a,c,d   Ferguson, David J ^a,e  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER COASTAL HEALTH   (Canada)

^c Children's and Women's Health Centre of BC

^d Transfusion Medicine Advisory Group of BC

^e BC Biomedical Laboratories Ltd

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34548474073     PISSN: 00070556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, et al.; British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004;126:11-28.
2. Stanworth SJ, Brunskill SJ, Hyde CJ, et al. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials, Br J Haematol 2004;126:139-152.
3. Ciavarella D, Reed RL, Counts RB, et al. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient, Br J Haematol 1987;67:365-368.
4. Domen RE, Kennedy MS, Jones LL, et al. Hemostatic imbalances produced by plasma exchange. Transfusion 1984;24: 336-339.
5. American Association of Blood Banks. American Association of Blood Banks Technical Manual. 14th ed. Bethesda, Maryland: AABB; 2002:461, 465.
6. Baker Rl, Coughlin PB, Gallus AS, et al. Warfarin Reversal Consensus Group. Warfarin reversal: Consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust 2004;181:492-497.
7. Estol CJ, Kase CS. Need for continued use of anticoagulants after intracerebral hemorrhage. CurrTreat Options Cardiovasc Med 2003;5:201-209.
8. Practice parameter for the use of freshfrozen plasma, cryoprecipitate, and platelets. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists. JAMA 1994;271:777-781.
9. Practice guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996;84:732-747
10. Expert Working Group, Guidelines for red blood cell and plasma transfusion for adults and children. CMAJ 1997; 156(11 suppl):S1-S24. www.cmaj.ca/cgi/content/full/156/11/DC1 (accessed 19 December 2006).
11. Dempfle CE. Coagulopathy of sepsis. Thromb Haemost 2004;91:213-224.
12. Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group, N Engl J Med 1991;325:393-397.
13. Rock G, Shumak KH, Sutton DM, et al. Cryosupematant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura, Members of the Canadian Apheresis Group, Br J Haematol 1996;94:383-386.
14. Zeigler ZR, Shadduck RK, Gryn JF et al. North American TTP Group. Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP). J Clin Apher 2001;16:19-22.
15. Rock G, Anderson D, ClarkW, et al. Canadian Apheresis Group; Canadian Association of Apheresis Nurses. Does cryosupematant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet. Br J Haematol 2005; 129:79-86.
16. Watson HG, Baglin T, Laidlaw SL, et al. A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin. Br J Haematol 2001;115:145-149.
17. Makris M, Greaves M, Phillips WS, et al. Emergency oral anticoagulant reversal: The relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 1997;77:477-480.
18. Yasaka M, Minematsu K, Naritomi H, et al. Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin. Thromb Haemost 2003;89:278-283.
19. Yasaka M, Sakata T, Minematsu K, et al. Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication. Thromb Res 2002;108:25-30.
20. Crowther MA, McDonald E, Johnston M, et al. Vitamin K deficiency and D-dimer levels in the intensive care unit: A prospective cohort study. Blood Coagul Fibrinolysis 2002;13:49-52.
21. MacLaren R, Wilson SJ, Campbell A, et al. Evaluation and survey of intravenous vitamin K1 for treatment of coagulopathy in critically ill patients. Pharmacotherapy 2001;21:175-182.
22. Youssef WI, Salazar F, Dasarathy S, et al. Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: A dual phase study. Am J Gastroenterol 2003;98:1391-1394.
23. McGill DB, Rakela J, Zinsmeister AR, et al. A 21-year experience with major hemorrhage after percutaneous liver biopsy, Gastroenterology 1990;99:1396-1400.
24. Terjung B, Lemnitzer I, Dumoulin FL, et al. Bleeding complications after percutaneous liver biopsy. An analysis of risk factors. Digestion 2003;67:138-145.
25. Dzik WH. Component therapy before bedside procedures. In: Mintz PD (ed). Transfusion Therapy: Clinical Principles and Practice. 2nd ed. Bethesda, MD: AABB Press; 2005:1-26.
26. Casbard AC, Williamson LM, Murphy MF, et al.The role of prophylactic fresh frozen plasma in decreasing blood loss and correcting coagulopathy in cardiac surgery. A systematic review, Anaesthesia 2004; 59:550-558.
27. ErberWN, Perry DJ. Plasma and plasma products in the treatment of massive haemorrhage. Best Pract Res Clin Haematol 2006;19:97-112.
28. Emery EF Greenough A, Gamsu HR. Randomised controlled trial of colloid infusions in hypotensive preterm infants, Arch Dis Child 1992;67(10SpecNo):1185- 1188.
29. Boralessa H, Modi N, Cockburn H, et al. RBC T activation and hemolysis in a neonatal intensive care population: Implications for transfusion practice. Transfusion 2002;42:1428-1434.
30. Northern Neonatal Nursing Initiative Trial Group. Randomised trial of prophylactic early fresh-frozen plasma or gelatin or glucose in preterm babies: Outcome at 2 years. Lancet 1996;348:229-232.
31. Supapannachart S, Siripoonya R Boonwattanasoontorn W, et al. Neonatal polycythemia: Effects of partial exchange transfusion using fresh frozen plasma, Haemaccel and normal saline. J Med AssocThai 1999;82(suppl 1):S82-86.